0001401708-21-000208.txt : 20210903 0001401708-21-000208.hdr.sgml : 20210903 20210903171324 ACCESSION NUMBER: 0001401708-21-000208 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210901 FILED AS OF DATE: 20210903 DATE AS OF CHANGE: 20210903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BEECHEM JOSEPH M CENTRAL INDEX KEY: 0001576195 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35980 FILM NUMBER: 211237417 MAIL ADDRESS: STREET 1: 530 FAIRVIEW AVENUE NORTH STREET 2: SUITE 2000 CITY: SEATTLE STATE: WA ZIP: 98109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NanoString Technologies Inc CENTRAL INDEX KEY: 0001401708 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 200094687 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 530 FAIRVIEW AVENUE NORTH CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-378-6266 MAIL ADDRESS: STREET 1: 530 FAIRVIEW AVENUE NORTH CITY: SEATTLE STATE: WA ZIP: 98109 4 1 wf-form4_163070359044319.xml FORM 4 X0306 4 2021-09-01 0 0001401708 NanoString Technologies Inc NSTG 0001576195 BEECHEM JOSEPH M 530 FAIRVIEW AVENUE N SEATTLE WA 98109 0 1 0 0 SVP, Research & Development Common Stock 2021-09-01 4 A 0 209 51.969 A 91384 D Common Stock 2021-09-02 4 S 0 13000 60.83 D 78284 D Common Stock 2021-09-02 4 S 0 10114 61.54 D 68270 D The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the NanoString Technologies, Inc. Employee Stock Purchase Plan ("ESPP"), for the ESPP Purchase Period (as defined in the ESPP) of March 1, 2021 through September 1, 2021. This transaction is also exempt under Rule 16b-3(c). The Purchase Period ending September 1, 2021 is the PUrchase Period comprising the Offering Period (as defined in the ESPP) that began March 1, 2021 and ended September 1, 2021. In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on September 1, 2021. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $60.24 to $61.23, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $61.32 to $61.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. /s/ Shannon Atchison, Attorney-in-fact 2021-09-03